The recommended schedule from clinical trials is: Weeks 1-4: 2.5 mg once weekly Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly Weeks 13-16: 10 mg once weekly Weeks 17-20: 12.5 mg once weekly Week 21+: 15 mg once weekly (maximum dose) Not everyone follows this exact schedule
the focus will be different, so these effects might not be as potent (or immediate), but they still may occur
Once reconstituted, peptide solutions should be stored at 28C and used within the manufacturer-specified stability window
By day five, the constant ache had softened
Importantly, inclusion on the 503A pathway would not represent FDA approval or confirmation of clinical efficacy, but rather a regulatory mechanism allowing compounding under specific conditions
aureus with KL1, followed by washing before macrophage infection, did not enhance antibiotic-mediated killing (Extended Data Fig